Joaquín J Alonso

发表

Coexistence of Low Vitamin D and High Fibroblast Growth Factor-23 Plasma Levels Predicts an Adverse Outcome in Patients with Coronary Artery Disease

F. Rodríguez‐Artalejo, J. Egido, I. Mahíllo-Fernández, 2014, PloS one.

NT-proBNP Levels Influence the Prognostic Value of Mineral Metabolism Biomarkers in Coronary Artery Disease

J. Egido, I. Mahíllo-Fernández, L. Blanco-Colio, 2022, Journal of clinical medicine.

The Prognostic Value of High-Sensitive Troponin I in Stable Coronary Artery Disease Depends on Age and Other Clinical Variables

J. Egido, L. Blanco-Colio, J. Martín-Ventura, 2015, Cardiology.

Early and late onset cardiotoxicity following anthracycline-based chemotherapy in breast cancer patients: Incidence and predictors.

J. Muñiz, C. Cristóbal, J. Alonso, 2023, International journal of cardiology.

Diastolic Dysfunction Following Anthracycline-Based Chemotherapy in Breast Cancer Patients: Incidence and Predictors.

J. Muñiz, C. Cristóbal, J. Alonso, 2015, The oncologist.

Cardiac Rehabilitation Increases Plasma Klotho Levels

J. A. Franco Peláez, J. Tuñón, Á. Aceña, 2024, Journal of clinical medicine.

Fibroblast growth factor 23 independently predicts adverse outcomes after an acute coronary syndrome

Ó. Lorenzo, J. Tuñón, Á. Aceña, 2023, ESC heart failure.

Important abnormalities of bone mineral metabolism are present in patients with coronary artery disease with a mild decrease of the estimated glomerular filtration rate

F. Rodríguez‐Artalejo, A. Ortiz, J. Egido, 2016, Journal of Bone and Mineral Metabolism.

Usefulness of a combination of monocyte chemoattractant protein-1, galectin-3, and N-terminal probrain natriuretic peptide to predict cardiovascular events in patients with coronary artery disease.

F. Rodríguez‐Artalejo, J. Egido, I. Mahíllo-Fernández, 2014, The American journal of cardiology.

N-Terminal Pro-Brain Natriuretic Peptide Plasma Levels Are Associated with Intermediate-Term Follow-Up Cancer in Coronary Patients

J. Egido, I. Mahíllo-Fernández, L. Blanco-Colio, 2021, Journal of clinical medicine.

N-Terminal Pro-Brain Natriuretic Peptide Is Associated with a Future Diagnosis of Cancer in Patients with Coronary Artery Disease

J. Egido, I. Mahíllo-Fernández, L. Blanco-Colio, 2015, PloS one.

Differential profile in inflammatory and mineral metabolism biomarkers in patients with ischemic heart disease without classical coronary risk factors.

J. Egido, I. Mahíllo-Fernández, L. Blanco-Colio, 2015, Journal of cardiology.

Circulating fibroblast growth factor‐23 plasma levels predict adverse cardiovascular outcomes in patients with diabetes mellitus with coronary artery disease

B. Fernández-Fernández, J. Egido, I. Mahíllo-Fernández, 2016, Diabetes/metabolism research and reviews.

Impacto de los niveles plasmáticos de pro-péptido natriurético tipo B aminoterminal, proteína quimiotáctica de monocitos-1 y galectina 3 en la capacidad predictiva de eventos de la escala clínica LIPID en la enfermedad coronaria estable

F. Rodríguez‐Artalejo, J. Egido, I. Mahíllo-Fernández, 2015 .

Comparison of 3 Predictive Clinical Risk Scores in 603 Patients with Stable Coronary Artery Disease.

I. Mahíllo-Fernández, Ó. Lorenzo, J. Tuñón, 2017, Texas Heart Institute journal.

Impact of renal function on the prognostic value of mineral metabolism in patients with chronic ischaemic heart disease patients with chronic ischaemic heart disease

J. Egido, I. Mahíllo-Fernández, L. Blanco-Colio, 2022, Clínica e Investigación en Arteriosclerosis (English Edition).

Parathormone levels add prognostic ability to N‐terminal pro‐brain natriuretic peptide in stable coronary patients

J. Egido, I. Mahíllo-Fernández, L. Blanco-Colio, 2021, ESC heart failure.

Important abnormalities of bone mineral metabolism are present in patients with coronary artery disease with mild decrease of estimated glomerular filtration rate Short title: CKD-MBD in coronary artery disease patients

F. Rodríguez‐Artalejo, J. Egido, I. Mahíllo-Fernández, 2016 .